Orgenesis Inc. (ORGS)

0.5040 +0.0020 (+0.40%) At close: 04:00PM EDT

Orgenesis Inc.

20271 Goldenrod Lane
Germantown, MD 20876
United States
480 659 6404
https://orgenesis.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 146

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Vered Caplan M.Sc.	Chairperson of the Board, CEO & President	341.38k	N/A	1969
Prof. Sarah Ferber Ph.D.	Founder & Chief Scientific Officer	268.32k	N/A	1954
Mr. Victor Miller	CFO, Secretary & Treasurer	N/A	N/A	1970
Pierre Lammeretz	Interim Chief Operating Officer	N/A	N/A	N/A
Dr. Shimon Hassin Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Mr. Evan Fishman	Chief Financial Officer of Orgenesis Biotech	N/A	N/A	N/A
Mr. Joseph Carpinelli	Chief Financial Officer of Octomera	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Orgenesis Inc., a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. The company also provides development services, including regulatory services, pre-clinical studies, intellectual property services, and GMP process translation, as well as support services; hospital services; cell process development services; and distributed cell processing services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland.

Corporate governance

Orgenesis Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.